We examined the effectiveness and safety of a walking program offered as part of cognitive behavioral therapy for chronic pain (CBT-CP). Participants were randomized to 10 weeks of CBT-CP, delivered either in person or by interactive voice response. Participants reported pedometer-measured step counts daily throughout treatment and received a weekly goal to increase their steps by 10% over the prior week’s average. Walking-related adverse events (AEs) were assessed weekly. Participants (n = 125) were primarily male (72%), and white (80%) with longstanding pain (median: 11 years). There was no significant difference between treatment groups in rate of change in daily steps, but there was a significant increase in steps from baseline to treatment termination in the combined study sample (1648 steps (95% CI 1063–2225)). Participants classified as active doubled. AEs were mostly minor and temporary. Treatment was effective and safe whether the program was delivered in-person or remotely.

Trial registration number: clinicaltrials.gov identifier: NCT01025752.

我们检查了作为慢性疼痛认知行为疗法 (CBT-CP) 的一部分提供的步行计划的有效性和安全性。参与者被随机分配到 10 周的 CBT-CP 中，亲自或通过交互式语音响应进行。参与者在整个治疗过程中每天报告计步器测量的步数，并接受每周目标，将他们的步数比前一周的平均值增加 10%。每周评估与步行相关的不良事件 (AE)。参加者（n = 125) 主要是男性 (72%) 和长期疼痛的白人 (80%)（中位数：11 年）。治疗组之间每日步数的变化率没有显着差异，但合并研究样本中从基线到治疗终止的步数显着增加（1648 步（95% CI 1063–2225））。被归类为活跃的参与者增加了一倍。AE 大多是轻微的和暂时的。无论该计划是亲自还是远程提供，治疗都是有效且安全的。

试验注册号：clinicaltrials.gov 标识符：NCT01025752。